Rival Biologics Bill Introduced In House
Another bill to create a regulatory process for the U.S. Food and Drug Administration to approve generic versions of biologic drugs was introduced in the U.S. House of Representatives on Tuesday...To view the full article, register now.
Already a subscriber? Click here to view full article